In a time of rapidly advancing technology, those who can study at the forefront of its development will have an advantage.

The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...

During the Spring Festival holiday, Hubei's top tourist sites introduced online ticketing and seamless entry for foreign ...

Horsebacked rescuer who held his mount's reins in one hand while pulling struggling man from water with the other was equine ...